News

Press Releases

Inflection Biosciences Selected as Tech Tour Contest Finalist for 2019

Dublin, Ireland, November 26, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...

Inflection Biosciences Announces Passing of Co-Founder and Board Member John Scanlan

Dublin, Ireland, October 30, 2019 – Inflection Biosciences Ltd today announced that John Scanlan, a co-founder and a member of its Board...

Inflection Biosciences Announces Pre-clinical Data to be Presented at IASLC 2019 World Conference.

Dublin, Ireland, September 9th, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...

Inflection Biosciences Announces Publication of Positive Data for PIM/PI3K/mTOR Inhibitor

Dublin, Ireland, August 7, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...

Inflection Biosciences and AUM Biosciences announce Global License Agreement for PIM/PI3K/mTOR

Dublin, Ireland, 18 July 2019 – Inflection Biosciences (Inflection), a company developing innovative therapeutics for the treatment of...